| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |